Hervor Therapeutics
Clinical trials sponsored by Hervor Therapeutics, explained in plain language.
-
Experimental cell therapy for Hard-to-Treat cancers hits early snag
Disease control TerminatedThis early-phase trial tested a new treatment called HV-101 for people with advanced solid tumors that had spread or come back. The therapy uses a patient's own immune cells (TILs) taken from their tumor, grown in a lab, and then given back along with chemotherapy and IL-2. The s…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Personalized cell therapy shows promise for Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested a personalized cancer treatment called tumor-infiltrating lymphocyte (TIL) therapy. Doctors took immune cells from each patient's own tumor, grew them in a lab, and infused them back to fight the cancer. The study enrolled only 5 adults with advanced…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC